Laddar...
Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®
Biosimilars are biological products that are highly similar to existing products approved by health authorities. Demonstration of similarity starts with the comprehensive analysis of the reference product and its proposed biosimilar at the physicochemical and functional levels. Here, we report the r...
Sparad:
| I publikationen: | MAbs |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Taylor & Francis
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5240642/ https://ncbi.nlm.nih.gov/pubmed/27854156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1259046 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|